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Abstract 
Artificial intelligence (AI) is about to touch every aspect of radiotherapy from consultation, treatment planning, 
quality assurance, therapy delivery, to outcomes modeling. There is an urgent need to train radiation oncologists 
and medical physicists in data science to help shepherd AI solutions into clinical practice. Poorly trained 
personnel may do more harm than good when attempting to apply rapidly developing and complex 
technologies. As the amount of AI research expands in our field, the radiation oncology community needs to 
discuss how to educate future generations in this area. The National Cancer Institute (NCI) Workshop on AI in 
Radiation Oncology (Shady Grove, MD, April 4-5, 2019) was the first 
(https://dctd.cancer.gov/NewsEvents/20190523_ai_in_radiation_oncology.htm) of two data science 
workshops in radiation oncology hosted by the NCI in 2019. During this workshop, the Training and Education 
Working Group was formed by volunteers among the invited attendees. Its members represent radiation 
oncology, medical physics, radiology, computer science, industry, and the NCI.  
In this perspective article written by members of the Training and Education Working Group, we provide and 
discuss Action Points relevant for future trainees interested in radiation oncology AI: (1) creating AI awareness 
and responsible conduct; (2) implementing a practical didactic curriculum; (3) creating a publicly available 
database of training resources; and (4) accelerate learning and funding opportunities. Together, these Action 
Points can facilitate the translation of AI into clinical practice. 
Introduction 
Artificial intelligence (AI) is a longstanding field of study that has attempted to emulate and augment human 
intelligence. In the last several years, AI has been reinvigorated by advances in computer technology and 
machine learning (ML) algorithms, which aim to teach computers to learn patterns and rules by using previous 
examples. ML builds on experiences from computer science, statistics, neuroscience, and control theory, among 
many other disciplines. ML has benefited from recent availability of large datasets and developments in 
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computers’ hardware and software for solving large-scale optimization problems. Most notably, deep learning 
(DL) techniques have demonstrated significant successes in computer vision and language processing. These 
advances are most visible in consumer quality-of-life improvements such as self-driving cars and voice-activated 
virtual assistants. The umbrella term “informatics” includes practical applications of any of the above areas of 
study; for example, bioinformatics for biology and clinical informatics (or biomedical informatics) for clinical 
practice. The term “data science” refers to the general study of data analysis, which has recently focused on ML 
methods. A schematic of the relationships between common terminologies is shown in Figure 1. 
 
Figure 1: Schematic of how artificial intelligence (AI), machine learning (ML), and deep learning (DL) relate to each other. 
Closely associated application areas such as “data analytics” and “big data” exist both within and outside of these realms. 
Salient examples include: AI includes expert systems using rules (if-then statements) and statistical ML; ML includes 
support vector machines and neural networks; DL includes deep neural networks and convolutional neural networks; big 
data can be described as data having volume, velocity, variety, veracity/variability, and value 
(https://www.ibm.com/blogs/watson-health/the-5-vs-of-big-data/); data analytics refers to the process of making 
meaningful predictions and models, as exemplified by the work of several authors referenced in this paper24,25,33,41,43,47. 
 
Many fields such as finance, manufacturing, and advertising have already incorporated AI into their workflows 
to improve efficiency and perform supra-human tasks. While AI has been adopted more slowly in the clinic due 
to multiple competing factors—including a lack of training—the perception and engagement of AI in medicine 
has been improving. The American Medical Association (AMA) adopted a policy in June 2019 to integrate 
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training in AI augmentation 1. The National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Initiative 
has established several Centers of Excellence in Data Science, and is focused on enhancing nationwide training 
infrastructure in biomedical data science as well as data sharing 2. Radiation oncology holds significant promise 
for AI-powered tasks—described in several perspectives and reviews 3–8—not just for optimizing workflows or 
diagnosis, but also more rewarding tasks such as prognostic prediction and personalized treatment 
recommendations.  
AI applications in radiation oncology span the domains of both medical physicists and radiation oncologists. 
Some applications, such as auto-segmentation and automated treatment planning, will be human-verifiable; in 
other words, a human can check the work of a computer prior to deployment. Other applications—survival 
prognostication, decision support, and genomics-based treatment planning are not human-verifiable at an 
individual scale and will thus require careful model development and validation. As applied research in these 
applications grows in radiation oncology, a commensurate growth in education is necessary to be able to build 
and validate trustworthy AI models that can be applied to the clinic. 
Separate surveys of trainees in radiation oncology and radiology reveal that the majority are interested in 
additional training in the AI or informatics 9,10. 
In the radiation oncology survey, the American Society of Radiation Oncology (ASTRO) queried chairs and 
trainees in 2017 to assess their perception of training and research opportunities in genomics, bioinformatics, 
and immunology.10 Among the three areas, bioinformatics received the most enthusiasm: 76% believed that 
bioinformatics training would “definitely or probably” advance their career. 67% expressed interest in a formal 
bioinformatics training course and 88% of chairs reported they would “probably or definitely” send faculty or 
trainees to such a course, reflecting an unmet need in training opportunities. Though the ASTRO survey did not 
specifically ask about AI/ML, we believe the high interest in bioinformatics accurately reflects interest in 
quantitative analysis in line with AI/ML methods11. In recognition of the need for radiation oncologists with 
specialized informatics training, the NCI, Oregon Health & Science University, and MD Anderson Cancer Center 
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have each created training programs specific for radiation oncology fellows/residents aimed for careers as 
medical director in informatics and/or formal board certification in clinical informatics 12. 
The radiology survey supports a sentiment towards AI that is similar to that in radiation oncology 13. A single 
institution survey of a radiology department revealed concerns about job security but also enthusiasm to learn 
about AI/ML 9. This survey showed that 97% of trainees (residents and fellows) were planning to learn AI/ML as 
relevant to their job (vs. 77% of attending radiologists). In fact, 74% of trainees (vs. 60% of attendings) were 
willing to help create or train an ML algorithm to do some of the tasks as a radiologist. National radiology 
societies have been responsive to these sentiments. The American College of Radiology (ACR) Data Science 
Institute (https://www.acrdsi.org/) recently launched the ACR AI-LAB™ to allow radiologists to create, validate 
and use models for their specific local clinical needs. The Radiological Society of North America (RSNA) and the 
Society for Imaging Informatics in Medicine (SIIM) co-sponsor the National Imaging Informatics Course, held 
twice a year (in its 3rd year); the majority of residency programs have participated 
(https://sites.google.com/view/imaging-informatics-course/). The RSNA annual meeting hosts several AI 
refresher courses and coding challenges in the new “AI Pavilion” with residents encouraged to participate. The 
SIIM Resident, Fellow, Doctoral Candidate, Student (RFDS) society hosts monthly journal clubs and promotes 
mentoring opportunities (https://siim.org/page/rfds_community_inter).  
In this perspective article written by the Training and Education Working Group of the NCI Workshop on AI in 
Radiation Oncology (Shady Grove, MD, April 4-5, 2019) 14, we propose an overall action plan for radiotherapy-
specific AI training that is comprised of the action points outlined in Table 1. We cover each action point (AP) in 
detail in this article.  
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Table 1: Main summary of recommendations from Action Points 
 
AP1: Create awareness and responsible conduct of AI 
● Teach the importance of consideration of ethics, disparities, bias, and fairness in AI 
AP2: Implement practical didactic curriculum 
● Curriculum should address the needs of medical physicists, radiation oncologists, and data scientists 
and their respective roles in the process. 
● Mandate incorporation of AI, Big Data, data privacy, and data science training into residency 
curricula 
● Reiterate the importance of promoting a data sharing culture through education and exposure 
AP3: Create publicly accessible resources 
● Create centralized, public repository of resources (seminal white papers, webinars, video-lectures, 
hackathons, datasets, code, etc.)  
● Develop and disseminate radiation-specific training tools to all institutions to democratize access and 
standardize training quality   
● Leverage trainee crowdsourcing efforts to annotate datasets for research and use annotated 
datasets for education towards model and AI skills development 
● Incorporate open source challenges for both technology development and educational purposes 
AP4: Accelerate learning and funding opportunities 
● Incorporate workshop model used by AACR, ESTRO and others for rapid learning opportunities 
● Leverage industry support and interest via AI fellowships and tutorial workshops 
● Identify applicable research grants specifically for trainees/new investigators 
Abbreviations: AACR: American Association for Cancer Research; AI: artificial intelligence; ESTRO: European 
Society for Radiotherapy and Oncology 
AP1: Create awareness and responsible conduct of AI  
In the last decade or so, we have seen several examples of ethical concerns and biases magnified by AI. When 
there are biases in the training data (e.g., certain populations or scenarios are over represented), then an 
algorithm that models correlations could propagate or even amplify these biases, leading to undesirable 
outcomes in deployment 15. This is particularly problematic as AI is sometimes viewed as being “objective” 
without consideration for the data generation process, which is often unknown.  
The European Union (EU) has recently released a seven-point action plan towards so-called “trustworthy” AI. 
This plan focuses on the ethical aspects of AI and includes: human agency and oversight; robustness and safety; 
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privacy and data governance; transparency; diversity, non-discrimination and fairness; societal and 
environmental well-being; and accountability (https://ec.europa.eu/futurium/en/ai-alliance-
consultation/guidelines). Similarly, the Food and Drug Administration (FDA) has taken similar steps towards 
regulation of AI applications in medicine 16. A key component of improving awareness is to be transparent and 
clearly document where and when an AI algorithm is used in any part of the clinical workflow. And in cases 
where AI is applied, researchers and physicians should also clarify whether the AI is an ML system—which are 
the more recent type of AI trained on large data and tend to be less interpretable—or an older rule-based 
system. ML and rule-based AI have different behaviors. For example, neural networks—a type of ML system—
are vulnerable to adversarial attacks 17,18. 
AP2: Implement practical didactic curriculum 
There are currently no educational guidelines for AI training in radiation oncology or medical physics residents. 
Serendipitously, there is an active discussion within the field about revising the radiation oncology resident 
training curriculum. While in depth discussion of all the factors at play is beyond the scope of discussion here, 
we refer readers to a pair of editorials by Amdur and Lee 19and Wallner et. al 20. In July 2020, the Accreditation 
Council for Graduate Medical Education made several changes to the radiation oncology residency curriculum.21 
The revisions are notable for mandating education in several new areas, including clinical informatics. We are 
pleased that the ACGME has the foresight to update training curriculum to include informatics and hope that 
this paper can serve to provide high-level guidance. 
In Action Point 2, we propose a high-level overview of a curriculum draft for trainees in medical physics and 
radiation oncology to adequately grasp the basic principles of AI. These principles are generalizable to medicine 
as a whole and have particular significance for interventional and informatics-heavy specialties such as radiation 
oncology. 
1. Responsible conduct of AI, bias, and disparities 
2. Methodology: data science basics 
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3. Interpreting data and models 
4. Practical experience and applications 
5. Data sharing: logistics and culture 
 
2.1 Responsible conduct of AI, bias, and disparities 
There is increasing concern that AI models influenced by bias will further perpetuate healthcare disparities for 
patients. The underlying reason behind why bias is retained in AI models is often related to training data which 
fails to represent the entire population equally. Because AI algorithms do not have a concept of “fairness”, 
surveillance of inherent bias with AI is typically left to those who designed the system.  As noted by the EU/FDA 
in Action Point 1, proper application of AI should aim to enhance positive social change and enhance 
sustainability and ecological responsibility. Particularly in medicine, rules and regulations should be put in place 
to ensure responsibility and accountability of AI systems, their users and their appropriate utilization. In the 
computer science and ML communities, there has been increasing efforts to improve the teaching of ethics and 
human-centered AI in coursework (https://stanfordcs181.github.io/)22. A complementary area of work is to 
develop methods to audit AI systems in order to identify potential systematic or cultural biases. Trainees must 
develop an appreciation for these critical complexities and potential limitations of AI.  
2.2 Methodology: data science basics 
Data features, structures, and algorithms form the foundation of AI applications. Unfortunately, quantitative 
analysis and critical data appraisal are not universally emphasized in medical or post-graduate education, 
particularly for physicians. As many ML techniques become published in general medical or oncology journals, 
it is incumbent upon editors and readers alike to have some basic facility with the techniques. Building a working 
knowledge of basic statistical concepts such as hypothesis testing, confidence intervals, and basic performance 
metrics will need to be introduced before more data structures and model-agnostic techniques such as data 
cleaning, cross validation, model fitting, bias-variance trade off, and advanced performance metrics, such as the 
widely-used but poorly-understood receiver operating curve23.  To de-mystify many of these topics, there are 
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existing high-quality online courses made broadly available, which will be further discussed in Action Point 2 
and Action Point 3. 
2.3 Interpreting data and models 
For proper clinical application of AI tools, physicians should be able to assess the validity of the data and the 
model-generation process. So-called “black box” models have such internal complexity that they are 
conceptualized as inputs mapped to outputs without any intent to understand how the mapping occurs. Several 
ML methods, including deep learning (DL) and most ensemble methods, fall into this categorization. While black 
box AI models can have excellent performance during training and internal validation, they often encounter 
problems generalizing when widely deployed. Understanding why a problem occurred can be difficult with 
“black box” models and is currently a very active area of AI research 18,24. 
One way to demonstrate data and model interpretability is through “use cases.” In medical research, there are 
well-known examples of the potential dangers of black box models related to confounding 25. Fortunately, 
researchers were able to catch these issues before deploying their models, which may not always be the case 
for complex datasets with nonobvious confounders. 
There is an ongoing discussion on the necessity of AI interpretability by the FDA 16,26 and the informatics 
community 27. All authors would agree that elevating the knowledge base of clinicians and physicists will 
certainly enable more innovation regardless of final regulatory plans. 
2.4 Practical experience and applications 
For trainees interested in applying data science to clinical practice, these opportunities should be encouraged 
and promoted.  
While medical physics and radiation oncology AI curricula could have significant overlap, there will necessarily 
be focuses on separate domains. In medical physics, instruction may cover methods for auto-segmentation, 
automated/adaptive treatment planning, and quality assurance. Radiation oncology trainees may be more 
interested in prognostic predictions and clinical decision support. In the future, as AI takes more of an 
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augmented intelligence role, there should be instruction for physicians for how to decide whether to accept, 
interrogate or reject recommendations. For example, physicians may need to determine whether there is 
sufficient rationale to accept an automatically generated plan or treatment recommendation using clinical and 
dosimetric information. 
Several radiation oncology departments have AI/ML researchers who could contribute to a training curriculum. 
These courses should be jointly taught to both physicists and physicians. We anticipate that common courses 
and collaboration between trainees in medical physics and radiation oncology will improve translation of AI 
methods into the clinic. Given that medical physicists already have quantitative training in methods with 
significant overlap with ML, we anticipate close collaboration between physicists and physicians. Indeed, this is 
the current status quo in most radiation oncology departments performing AI/ML research. 
For departments without access to sufficient resources, online education using so-called MOOCs (“massive open 
online courses;” a misnomer as they are not necessarily massive or open) and workshop models (see Action 
Point 4) may be more educational to trainees than co-opting faculty without training in AI/ML. 
For advanced practitioners, we will discuss data science hackathons and crowdsourcing in Action Point 3. 
2.5 Data sharing: logistics and culture 
One of the key aspects of creating robust predictive models is being able to show generalization to novel 
datasets through a process called external validation, which requires institutions to share data among 
themselves. The data sharing culture in medicine has been historically tribalistic but has gradually become more 
collaborative. This dynamic was well exemplified by the backlash to an infamous 2016 editorial (co-authored by 
then-editor-in-chief of the New England Journal of Medicine) that was viewed as anti-data sharing 28,29. Unlike 
in academic medicine, academic AI researchers have a strong open-access culture where pre-print archiving of 
publications is the norm and datasets are simultaneously published with papers to invite validation. Notably, 
patients are generally supportive of the sharing of their data and would likely embrace scientific reuse of their 
data to improve the lives of future patients 30, though we recognize that there are many regulatory limitations 
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to widespread data sharing of this sort. Finding a path for controlled data sharing amongst trusted parties, or 
more broadly with de-identification schemes could be an important first step in improving the accuracy of AI 
algorithms. 
In this curriculum, we hope to emphasize the efforts in medicine and oncology to promote data sharing (Table 
2).  
Table 2: Examples of data sharing initiatives in oncology 
 
Entity Est. Area 
The Cancer Genome Atlas 
(TCGA) 
2005 Tumor genomics 
ACR Imaging Network/TRIAD 2009 Clinical trial protocols, datasets, cloud-based data transfer 
Radiogenomics Consortium 2009 Radiotherapy genomics/genetics 
The Cancer Imaging Archive 
(TCIA) 
2010 DICOM, radiomics. Select datasets with genomics, histopathology. 
ASCO CancerLinQ 2014 Quality improvement. Plan for decision support. 
Project DataSphere 2014 Phase III cancer clinical trial patient-level data 
ACR Data Science Institute 2017 Use cases in for development of medical imaging AI 
NCI Office of Data Sharing 2018 Advocacy, establishing standards, defining incentives 
Abbreviations. ACR: American College of Radiology; DICOM: Digital Imaging and Communications in Medicine; AI: artificial 
intelligence; ASCO: American Society of Clinical Oncology; Est.: established year; NCI: National Cancer Institute; TRIAD: 
Transfer of Images and Data 
 
The NCI is keen on improving data sharing protocols and resources. In 2018, the NCI Office of Data Sharing (ODS) 
was created and the NIH has recently asked for open comments on a draft policy for data management and 
sharing 31. The Cancer Imaging Archive (TCIA) is funded by NCI and allows the sharing of anonymized imaging 
datasets as well as corresponding clinical and genomic data. A radiology initiative includes the ACR Imaging 
Network (ACRIN) for clinical trial protocol and dataset sharing through TRIAD (Transfer of Images and Data). The 
American Society of Clinical Oncology (ASCO) provides another strong example of centralized data sharing in 
the CancerLinQ project (https://cancerlinq.org/). Radiation oncology currently lacks a specialty-specific 
centralized platform for data request and sharing. A notable effort to move towards this goal is by American 
Association of Physicists in Medicine (AAPM) Task Group 263 to standardize nomenclature using structured 
ontology for data pooling 32. 
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One approach to overcome data transfer medicolegal/PHI issues is through distributed or federated learning. In 
this approach, analysis is performed locally and models are transferred (e.g., feature weights) instead of data; 
this decentralized approach has shown equivalent performance to that using central pooling of data 33,34. Such 
innovative approaches for anonymization could be part of a training curriculum to help overcome barriers to 
data sharing. 
Recent years have seen signs of a cultural shift in radiation oncology towards open collaboration and data 
sharing, along with formalization of key principles in data sharing, namely that data should be FAIR: findable, 
accessible, interoperable, and reusable. These FAIR guiding principles for scientific data management and 
stewardship 35 are of utmost importance, and should be discussed with and endorsed for all trainees. In line 
with FAIR, several radiation oncology academic centers and cooperative groups have contributed datasets to 
the TCIA 36–38. Open access journals with a focus on radiation oncology include BMC Radiation Oncology, the 
Frontiers in Oncology section on radiation oncology, and Advances in Radiation Oncology, which was launched 
by ASTRO in 2015. 
Several coordinating efforts present opportunities to pool ideas and data to promote collaborating, increase 
power for discovery, and avoid redundancy. Within imaging, these efforts include the aforementioned ACR Data 
Science Institute for AI in medical imaging, which aims to identify clinically-impactful use cases in radiation 
oncology, such as auto-segmentation and MRI-derived synthetic CT scans 39. Within genomics, the 
Radiogenomics Consortium is a transatlantic cooperative effort pooling American and European cohorts to find 
genomic markers for toxicity to radiotherapy 40. Several groups within the consortium are interested in creating 
ML models to predict toxicity response in radiotherapy 41–44. 
Through the proposed curriculum draft of Action Point 2, we hope to build a core of trainees for the next 
generation who can understand and apply data science fundamentals while also understanding ethical 
considerations and data sharing principles. 
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AP3: Create publicly accessible resources 
Directly building off the curriculum discussed in Action Point 2, the third Action Point relates to the creation of 
a centralized, publicly accessible repository of resources to guide trainees. These resources could include 
seminal white papers, video lectures, code samples, and contacts for potential collaborations. To reach the 
widest potential audience, we favor storage at open access websites such as GitHub and Youtube, for instance. 
As discussed in Action Point 2, a formal curriculum can be facilitated and standardized using MOOCs, which 
would consist of video lectures and interactive coding exercises. MOOCs have become very influential in online 
education as they can be tailored for various experience levels and are self-paced. Due to economies of scale, 
they can be widely disseminated for reasonable costs. For example, the MOOCs on Coursera run on the higher 
end of cost and charges around $40/month for classes that last around a month with around 10-12 hours of 
coursework a week. MOOCs could be adopted from existing courses or centrally created in collaboration with 
organizations such as the Association of Residents in Radiation Oncology (ARRO) Education Committee and 
Radiation Oncology Education Collaborative Study Group (ROECSG). 
As there is more interest, trainees will likely want to be involved in practical research projects. Given that AI 
expertise is not evenly distributed, both intra- and inter-institutional collaborations can be fostered. In this 
respect, trainees can provide a valuable service by annotating data for research. At the same time, they would 
also benefit from the service of others by receiving annotated data for model and skills development. A model 
for this can be seen in eContour (https://www.econtour.org), a free web-based contouring atlas. In a 
randomized trial, eContour improved nasopharynx contours and anatomy knowledge compared to traditional 
resources 45. A next phase of eContour may involve enabling user-generated contours and segmentations for 
technology development and research, with a prototype initially pilot-tested at the American College of 
Radiation Oncology Annual Meeting in 2017 (http://www.econtour.org/acro). Researchers are invited to use 
the platform to collect contours from large numbers of users from diverse practice locations, though must 
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provide funding to support website programming and content administration. For residents, funding 
opportunities are available through professional organizations, as discussed in Action Point 4. 
Another promising venue for trainees interested in skills development is through public competitions (Table 3).  
Table 3: Examples of data science competitions in oncology and medicine 
Platform Year Prediction Goal 
MICCAI Brain 
Tumor Segmentation (BraTS) 
benchmark 
2012-
2020 
Segment heterogeneous brain tumors (gliomas) 
Prostate Cancer DREAM Challenge 2015 Predict overall survival and docetaxel discontinuation in 
mCRPC 
Kaggle Data Science Bowl  2016 Predict heart ejection fraction 
MICCAI radiomics challenges (2) 2016 (1) HPV (2) local control in oropharyngeal cancer 
Kaggle Data Science Bowl  2017 Detect lung cancer via National Lung Screening Trial DICOMs 
TopCoder Lung Cancer Challenge 2017 Segment lung cancer 
Kaggle Data Science Bowl  2018 Detect cellular nuclei 
Abbreviations. DICOM: Digital Imaging and Communications in Medicine; DREAM: Dialogue for Reverse Engineering 
Assessments and Methods; HPV: human papillomavirus; MICCAI: Medical Image Computing and Computer Assisted 
Intervention Society; mCRPC: metastatic castrate resistant prostate cancer 
 
Past challenges in radiation oncology have leveraged collaborations between academic centers, international 
societies such as MICCAI (The Medical Image Computing and Computer Assisted Intervention Society) and 
commercial sites such as TopCoder.com (Wipro, Bengalaru, India) and Kaggle.com (Google, San Francisco, CA). 
These public crowd-sourcing challenges have included two radiomics challenges (to predict human 
papillomavirus status or local control) in oropharyngeal cancer after radiotherapy 46 and to predict lung tumor 
segmentation 47. Within the medical computer vision domain, MICCAI hosts several challenges every year to 
help validate and benchmark image processing algorithms (http://www.miccai.org/events/challenges); regular 
challenges have included melanoma diagnosis, brain tumor segmentation,  and prostate cancer Gleason 
grading. In the data science competition space as a whole, there has been enthusiasm for healthcare challenges, 
with the last three Kaggle Data Science Bowls (https://datasciencebowl.com/) focused on heart ejection fraction 
determination (2016), lung cancer screening (2017), and cellular nuclei detection (2018).  
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AP4: Accelerate learning and funding opportunities 
Developing and maintaining resources described in Action Point 3 will require accelerated learning of 
particularly motivated trainees who will need institutional infrastructure and funding mechanisms to be 
successful. 
While MOOCs provide consistency and quality of education, for accelerated training, the radiation oncology 
community could adopt the intensive weeklong workshop model that is widely used by oncology organizations 
11. Examples include separate workshops on clinical trial development by ASCO/AACR 
(https://vailworkshop.org/) and ECCO-AACR-EORTC-ESMO (https://www.ecco-org.eu/Events/MCCR-
Workshop/EDITION-20) as well as the AACR Molecular Biology in Clinical Oncology Workshop which focuses on 
molecular biology methods and grantsmanship (https://www.aacr.org/meeting/mbco-2020/). These intensive 
week-long workshops are run by established faculty and are aimed at the research career development of senior 
trainees and junior faculty with a strong focus on mentorship; this workshop model could be adopted in 
radiation oncology to mentor trainees in data science. The aforementioned ASTRO 2017 survey10 suggests this 
workshop model could be well received with 88% of radiation oncology chairs “probably or definitely” be willing 
to send faculty or trainees to such a course to learn bioinformatics.  
Table 4: Examples of data science workshops in radiation oncology 
Workshop Date Host(s) 
AAPM Practical Big Data Workshop May 19-20, 2017 University of Michigan 
AAPM Practical Big Data Workshop May 31-June 2, 2018 University of Michigan 
EORTC State of Science meeting September 26-27, 
2018 
EORTC 
AAPM Practical Big Data Workshop June 6-8, 2019 University of Michigan 
NCI Workshop on AI in Radiation 
Oncology 
April 4-5, 2019 NCI Radiation Research Program 
NCI State of Data Science in Radiation 
Oncology 
July 25, 2019 NCI Radiation Oncology Branch, NCI Center 
for Strategic Scientific Initiatives 
2nd Annual NRG Radiation Oncology Mini-
Symposium: “AI and Machine Learning in 
Radiation Oncology” 
January 10, 2020 NRG Radiation Oncology Committee, NRG 
Center for Innovation in Radiation 
Oncology 
NRG Oncology Digital Health Workshop January 10, 2020 NRG Oncology 
Abbreviations. AAPM: American Association of Physicists in Medicine; AI: Artificial Intelligence; ASTRO: American Society 
for Radiation Oncology; EORTC: European Organisation for Research and Treatment of Cancer, NCI: National Cancer 
Institute. 
16 
 
Radiation oncology-specific workshops (Table 4) such as the Practical Big Data Workshop48 (hosted by the 
University of Michigan annually 2017-2019) and two ad hoc workshops by the NIH/NCI in 2019 (NCI Workshop 
on AI in Radiation Oncology in April14 and the NCI State of Data Science in radiation Oncology in July49) and the 
have provided forums for data science practitioners to discuss results and ideas, but have not yet had a primary 
focus on education or research mentorship. A joint ASTRO/AAPM AI research workshop planned for June 2020 
was cancelled due to the COVID-19 pandemic (https://www.astro.org/Meetings-and-Education/Live-
Meetings/2020/Research-Workshop). Other promising avenues for future AI education and workshops include 
annual society (ASTRO, AAPM, etc.) and cooperative group meetings. For example, recent EORTC50 and NRG 
Oncology meetings (https://www.nrgoncology.org/Resources/Meetings/January-2020-Semiannual-Meeting-
Resources) have included workshops on AI/digital health and may be able to incorporate educational content. 
Another avenue to gain expertise during radiation oncology residency could be through the American Board of 
Radiology’s B. Leonard Holman Research Pathway. This pathway is an established research fellowship during 
residency that provides between 18-21 protected months of research without lengthening clinical training time. 
This protected time could be used to gain expertise in data science, which could include MOOCs or AI fellowships 
in collaboration with data science departments or industry. Several companies, including Google, Microsoft, 
nVidia, and Facebook all offer 1-year AI “residencies” for specific areas such as deep learning. In late 2019, 
ASTRO and Varian Medical Systems announced a joint 1-year research fellowship to start in July 2020 for eligible 
residents (https://www.astro.org/Patient-Care-and-Research/Research/Funding-Opportunities/ASTRO-Varian-
Award); research topics include AI, information systems, and related areas. 
There are several grant opportunities for residents and fellows that could be utilized towards AI/ML research or 
education. These include 1-year grants of $25-50k by ASTRO (physicians and physicists), RSNA, and ASCO. There 
are also additional funding opportunities not specific to trainees by the Radiation Oncology Institute and 
radiotherapy companies. For new faculty, NIH K08/K23 awards can provide mentored research time and salary 
support. NIH R25 grants for developing informatics tools for cancer are another promising avenue for multi-year 
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funding opportunities. RSNA offers several grants for education (https://www.rsna.org/research/funding-
opportunities/education-grants) and had a specific focus on developing AI education tools for their 2020 
Education Innovation Grant. 
Conclusions 
AI is becoming a transformative force in medicine but there are dangers to blindly trust trained models and raw 
data without understanding their governance. Just as radiation oncology trainees should understand requisite 
radiobiology and physics to treat patients, we believe that some level of competency in AI is necessary to safely 
and effectively utilize it in the clinical setting. In this perspective article from the 2019 NCI Workshop on AI in 
Radiation Oncology: Training and Education Working Group, we have discussed AI awareness and proper 
conduct (Action Point 1), what an AI curriculum might include (AP2), how to create and contribute to 
educational resources (AP3), and what support from institutions, societies, and funding agencies is required 
(AP4). We hope that this paper will spark further discussion on the future of trainee education in radiation 
oncology. One concrete path forward could be for radiation oncologists and medical physicists to collaboratively 
apply for fellowships/funding and develop workshops (AP4) for creation of data science educational curricula 
(AP2) and resources (AP3), while being mindful of the ethical concerns in AI implementation (AP1). 
Disclaimer 
The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States 
Government. 
References 
1.  American Medical Association. AMA Adopt Policy, Integrate Augmented Intelligence in Physician Training.; 
2019. https://www.ama-assn.org/press-center/press-releases/ama-adopt-policy-integrate-augmented-
intelligence-physician-training. Accessed June 18, 2019. 
18 
 
2.  Margolis R, Derr L, Dunn M, et al. The National Institutes of Health’s Big Data to Knowledge (BD2K) 
initiative: capitalizing on biomedical big data. J Am Med Inform Assoc. 2014;21(6):957-958. 
doi:10.1136/amiajnl-2014-002974 
3.  Lambin P, van Stiphout RG, Starmans MH, et al. Predicting outcomes in radiation oncology—multifactorial 
decision support systems. Nature reviews Clinical oncology. 2013;10(1):27-40. 
doi:10.1038/nrclinonc.2012.196 
4.  Kang J, Schwartz R, Flickinger J, Beriwal S. Machine Learning Approaches for Predicting Radiation Therapy 
Outcomes: A Clinician’s Perspective. Int J Radiat Oncol Biol Phys. 2015;93(5):1127-1135. 
doi:10.1016/j.ijrobp.2015.07.2286 
5.  Bibault JE, Giraud P, Burgun A. Big Data and machine learning in radiation oncology: State of the art and 
future prospects. Cancer Lett. 2016;382(1):110-117. doi:10.1016/j.canlet.2016.05.033 
6.  Coates J, Souhami L, El Naqa I. Big Data Analytics for Prostate Radiotherapy. Front Oncol. 2016;6:149. 
doi:10.3389/fonc.2016.00149 
7.  Feng M, Valdes G, Dixit N, Solberg TD. Machine Learning in Radiation Oncology: Opportunities, 
Requirements, and Needs. Front Oncol. 2018;8. doi:10.3389/fonc.2018.00110 
8.  Thompson RF, Valdes G, Fuller CD, et al. Artificial intelligence in radiation oncology: A specialty-wide 
disruptive transformation? Radiother Oncol. 2018;129(3):421-426. doi:10.1016/j.radonc.2018.05.030 
9.  Collado-Mesa F, Alvarez E, Arheart K. The Role of Artificial Intelligence in Diagnostic Radiology: A Survey at 
a Single Radiology Residency Training Program. J Am Coll Radiol. 2018;15(12):1753-1757. 
doi:10.1016/j.jacr.2017.12.021 
10.  Mouw KW, Beck TF, Keen JC, Dicker AP. Assessing the Training and Research Environment for Genomics, 
Bioinformatics, and Immunology in Radiation Oncology. JCO Clinical Cancer Informatics. 2018;(2):1-9. 
doi:10.1200/CCI.18.00045 
11.  Thompson RF, Fuller CD, Berman AT, Aneja S, Thomas CR. Career Enrichment Opportunities at the Scientific 
Frontier in Radiation Oncology. JCO Clinical Cancer Informatics. 2019;(3):1-4. doi:10.1200/CCI.18.00126 
12.  Kang J, Thompson RF, Fuller CD, Camphausen KA, Gabriel PE, Thomas CR. In Regard to Wallner et al. 
International Journal of Radiation Oncology • Biology • Physics. 2020;106(1):217-218. 
doi:10.1016/j.ijrobp.2019.10.044 
13.  Pakdemirli E. Artificial intelligence in radiology: friend or foe? Where are we now and where are we 
heading? Acta Radiol Open. 2019;8(2). doi:10.1177/2058460119830222 
14.  NCI Convenes Workshop on Artificial Intelligence (AI) in Radiation Oncology | News & Events | DCTD. In: 
National Cancer Institute; 2019. 
https://dctd.cancer.gov/NewsEvents/20190523_ai_in_radiation_oncology.htm. Accessed July 26, 2019. 
15.  Zou J, Schiebinger L. AI can be sexist and racist — it’s time to make it fair. Nature. 2018;559(7714):324. 
doi:10.1038/d41586-018-05707-8 
19 
 
16.  FDA, U. S. Food & Drug Administration. Clinical and Patient Decision Support Software Draft Guidance.; 
2017. 
17.  Goodfellow IJ, Shlens J, Szegedy C. Explaining and Harnessing Adversarial Examples. arXiv:14126572 [cs, 
stat]. March 2015. http://arxiv.org/abs/1412.6572. Accessed April 20, 2020. 
18.  Ghorbani A, Abid A, Zou J. Interpretation of Neural Networks is Fragile. arXiv:171010547 [cs, stat]. October 
2017. http://arxiv.org/abs/1710.10547. Accessed June 20, 2019. 
19.  Lee WR, Amdur RJ. A Call for Change in the ABR Initial Certification Examination in Radiation Oncology. 
International Journal of Radiation Oncology • Biology • Physics. 2019;104(1):17-20. 
doi:10.1016/j.ijrobp.2018.12.046 
20.  Wallner PE, Kachnic LA, Alektiar KM, Davis BJ, Hardenbergh PH, Ng AK. The American Board of Radiology 
Initial Certification in Radiation Oncology: Moving Forward Through Collaboration. International Journal of 
Radiation Oncology • Biology • Physics. 2019;104(1):21-23. doi:10.1016/j.ijrobp.2019.01.090 
21.  ACGME. Radiation Oncology. Radiation Oncology Program Rrequirements and FAQs. 
https://acgme.org/Specialties/Program-Requirements-and-FAQs-and-
Applications/pfcatid/22/Radiation%20Oncology. Published July 1, 2020. Accessed April 5, 2020. 
22.  University S. Stanford University launches the Institute for Human-Centered Artificial Intelligence. Stanford 
News. https://news.stanford.edu/2019/03/18/stanford_university_launches_human-centered_ai/. 
Published March 18, 2019. Accessed September 8, 2019. 
23.  Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) 
curve. Radiology. 1982;143(1):29-36. doi:10.1148/radiology.143.1.7063747 
24.  Caruana R, Lou Y, Gehrke J, Koch P, Sturm M, Elhadad N. Intelligible Models for HealthCare: Predicting 
Pneumonia Risk and Hospital 30-day Readmission. In: Proceedings of the 21th ACM SIGKDD International 
Conference on Knowledge Discovery and Data Mining. KDD ’15. New York, NY, USA: ACM; 2015:1721–1730. 
doi:10.1145/2783258.2788613 
25.  Zech JR, Badgeley MA, Liu M, Costa AB, Titano JJ, Oermann EK. Variable generalization performance of a 
deep learning model to detect pneumonia in chest radiographs: A cross-sectional study. PLOS Medicine. 
2018;15(11):e1002683. doi:10.1371/journal.pmed.1002683 
26.  Evans B, Ossorio P. The Challenge of Regulating Clinical Decision Support Software After 21(st) Century 
Cures. Am J Law Med. 2018;44(2-3):237-251. doi:10.1177/0098858818789418 
27.  AMIA Urges More Work on FDA’s Decision Support Guidance | AMIA. https://www.amia.org/news-and-
publications/press-release/amia-urges-more-work-fda%E2%80%99s-decision-support-guidance. 
Accessed April 21, 2019. 
28.  Frellick M. NEJM Editor Backtracks on Data-Sharing “Parasites” Editorial. Medscape. 
http://www.medscape.com/viewarticle/857756. Published January 26, 2016. Accessed April 6, 2020. 
20 
 
29.  Husten L. NEJM Editor Flip Flops On Data Sharing After Social Media Firestorm. CardioBrief. 
http://www.cardiobrief.org/2016/01/25/nejm-editor-flip-flops-on-data-sharing-after-social-media-
firestorm/. Published January 25, 2016. Accessed April 6, 2020. 
30.  Patient-Led Data Sharing — A New Paradigm for Electronic Health Data. NEJM Catalyst. 
https://catalyst.nejm.org/patient-led-health-data-paradigm/. Published November 21, 2018. Accessed 
April 28, 2019. 
31.  Wolinetz CD. NIH’s DRAFT Data Management and Sharing Policy: We Need to Hear From You! Office of 
Science Policy. November 2019. https://osp.od.nih.gov/2019/11/06/draft-data-management-and-sharing-
policy-we-need-to-hear-from-you/. Accessed April 25, 2020. 
32.  Mayo CS, Moran JM, Bosch W, et al. American Association of Physicists in Medicine Task Group 263: 
Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018;100(4):1057-1066. 
doi:10.1016/j.ijrobp.2017.12.013 
33.  Jochems A, Deist TM, El Naqa I, et al. Developing and Validating a Survival Prediction Model for NSCLC 
Patients Through Distributed Learning Across 3 Countries. International Journal of Radiation 
Oncology*Biology*Physics. 2017;99(2):344-352. doi:10.1016/j.ijrobp.2017.04.021 
34.  Chang K, Balachandar N, Lam C, et al. Distributed deep learning networks among institutions for medical 
imaging. J Am Med Inform Assoc. 2018;25(8):945-954. doi:10.1093/jamia/ocy017 
35.  Wilkinson MD, Dumontier M, Aalbersberg IjJ, et al. The FAIR Guiding Principles for scientific data 
management and stewardship. Sci Data. 2016;3. doi:10.1038/sdata.2016.18 
36.  Aerts HJWL, Rios Velazquez E, Leijenaar RTH, et al. Data From NSCLC-Radiomics. 2015. 
doi:10.7937/k9/tcia.2015.pf0m9rei 
37.  Bradley J, Forster K. Data from NSCLC-Cetuximab. 2018. doi:10.7937/tcia.2018.jze75u7v 
38.  Grossberg AJ, Mohamed ASR, Elhalawani H, et al. Imaging and clinical data archive for head and neck 
squamous cell carcinoma patients treated with radiotherapy. Scientific Data. 2018;5:180173. 
doi:10.1038/sdata.2018.173 
39.  Thompson RF, Valdes G, Fuller CD, et al. Artificial Intelligence in Radiation Oncology Imaging. International 
Journal of Radiation Oncology • Biology • Physics. 2018;102(4):1159-1161. 
doi:10.1016/j.ijrobp.2018.05.070 
40.  West C, Rosenstein BS. Establishment of a Radiogenomics Consortium. International Journal of Radiation 
Oncology • Biology • Physics. 2010;76(5):1295-1296. doi:10.1016/j.ijrobp.2009.12.017 
41.  Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide 
association studies to predict radiotherapy complications and to identify correlative molecular processes. 
Sci Rep. 2017;7:43381. doi:10.1038/srep43381 
42.  Kang J, Rancati T, Lee S, et al. Machine Learning and Radiogenomics: Lessons Learned and Future 
Directions. Front Oncol. 2018;8:228. doi:10.3389/fonc.2018.00228 
21 
 
43.  Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH. Machine Learning on a Genome-wide Association 
Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. Int J Radiat Oncol Biol Phys. 
2018;101(1):128-135. doi:10.1016/j.ijrobp.2018.01.054 
44.  Kang J, Coates JT, Strawderman RL, Rosenstein BS, Kerns SL. Genomics models in radiotherapy: from 
mechanistic to machine learning. arXiv:190409662 [q-bio, stat]. April 2019. 
http://arxiv.org/abs/1904.09662. Accessed July 19, 2019. 
45.  Gillespie EF, Panjwani N, Golden DW, et al. Multi-institutional Randomized Trial Testing the Utility of an 
Interactive Three-dimensional Contouring Atlas Among Radiation Oncology Residents. Int J Radiat Oncol 
Biol Phys. 2017;98(3):547-554. doi:10.1016/j.ijrobp.2016.11.050 
46.  Elhalawani H, Lin TA, Volpe S, et al. Machine Learning Applications in Head and Neck Radiation Oncology: 
Lessons From Open-Source Radiomics Challenges. Front Oncol. 2018;8:294. doi:10.3389/fonc.2018.00294 
47.  Mak RH, Endres MG, Paik JH, et al. Use of Crowd Innovation to Develop an Artificial Intelligence–Based 
Solution for Radiation Therapy Targeting. JAMA Oncol. 2019;5(5):654-661. 
doi:10.1001/jamaoncol.2019.0159 
48.  Mackie TR, Jackson EF, Giger M. Opportunities and challenges to utilization of quantitative imaging: Report 
of the AAPM practical big data workshop. Medical Physics. 2018;45(10):e820-e828. doi:10.1002/mp.13135 
49.  Jain AK, Berny-Lang M. State of Data Science in Radiation Oncology Workshop. In: NIH National Cancer 
Institute; 2019. https://events.cancer.gov/ccr/row. Accessed July 22, 2019. 
50.  Thomas G, Eisenhauer E, Bristow RG, et al. The European Organisation for Research and Treatment of 
Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. European 
Journal of Cancer. 2020;131:76-88. doi:10.1016/j.ejca.2020.02.050 
 
 
